Drug
Balugrastim
Balugrastim: highest development phase Phase 2/3, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| Balugrastim NCT00837265 | Phase 2/3 | Chemotherapy-induced Neutropenia |
Latest
No recent events.
Follow Balugrastim on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.